JPRN-jRCT2080221930未知3 期
ong-term safety study of KRP-AB1102 in japanese patients with chronic obstructive pulmonary disease (COPD)
Kyorin Pharmaceutical Co.,LTD.0 个研究点目标入组 130 人开始时间: 2012年9月27日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 40age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Adult male or female COPD patients aged >= 40, and others.
排除标准
- •- History or current diagnosis of asthma
- •- Patient changed drug treatment for COPD within 4 weeks prior to screening visit, and others.
研究者
相似试验
已完成
3 期
ong-term study of KRP-108Bronchial asthmaJPRN-jRCT2080223577Kyorin Pharmaceutical Co.,LTD53
进行中（未招募）
1 期
An extension study of safety of canakinumab in Japanese patients with periodic fever syndromesThree disease of periodic fever syndromes, TNF receptor Associated Periodic Syndrome (TRAPS), Hyper IgDSyndrome (HIDS)/ Mevalonate Kinase Deficiency (MKD) and Familial Mediterranean Fever (FMFMedDRA version: 20.0Level: SOCClassification code 10010331Term: Congenital, familial and genetic disordersSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2017-001678-40-Outside-EU/EEAovartis pharma AG4
已完成
不适用
A Study to Evaluate the Safety and Effectiveness of the Left Atrial Appendage Closure Therapy Using BSJ003WAtrial Fibrillation Non-RheumaticNCT03033134Boston Scientific Japan K.K.54
已完成
1 期
A phase I clinical study of KSP-0243Healthy ConditionJPRN-jRCT2071200087Shimizu Yoshitaka144
已完成
3 期
A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease ParticipantsParkinson's DiseaseNCT02337751Takeda198